Latest News
News Functions
Additional Functions
13 November 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA announces annual General Meeting Resolutions
9 October 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to update on RBCARE business combination
3 October 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA and RBCARE2023 signed to combine their businesses
30 September 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA discloses its half-year figures 2023
28 September 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V.
30 August 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA filed the appeal on SIX decision of delisting
4 August 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to update on SIX decision
31 July 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA discloses its Annual Report 2022
31 May 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to apply for a further extension of its disclosure obligations
30 May 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to update on strategic refocusing decisions.
15 May 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters
1 May 2023
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to get SIX approval to Annual Report 2022 disclosure
30 October 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: Igea discloses its 2022 Half-Year Financial Report
20 October 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA DISCLOSES ITS 2021 ANNUAL REPORT
30 September 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to get SIX approval to the semi-annual 2022 report disclosure
9 August 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure
15 July 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure
13 July 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA PHARMA HAS ANNOUNCED THAT LMH – AN INDUSTRIAL HOLDING COMPANY – HAS COMPLETED THE DUE DILIGENCE PROCESS FOR A EURO 6.000.000 COMMITTMENT TO FUND THE SWISS CBD EXTRACTION FACILIT
15 June 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure
8 June 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMITTMENT TO FUND THE COMPLETION OF ITS SWISS CBD EXTRACTION FACILITY
2 May 2022
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA to get SIX approval to delay the 2021 annual report disclosure
25 November 2021
IGEA Pharma N.V.
IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05
4 October 2021
IGEA Pharma N.V.
IGEA Pharma N.V.: GBC AG TO START EQUITY COVERAGE OF IGEA PHARMA
30 September 2021
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA DISCLOSES ITS HALF-2021 FINANCIALS
27 September 2021
IGEA Pharma N.V.
IGEA Pharma N.V.: IGEA HAS BEEN GRANTED THE LISTING OF THE NEW SHARES FROM SIX EXCHANGE REGULATION.
2 August 2021
IGEA Pharma N.V.
IGEA PHARMA TO BOOST REVENUES ENTERING THE GROWING CANNABIS MARKET
26 July 2021
IGEA Pharma N.V.
IGEA ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD NOW UNCONDITIONAL AS TO ACCEPTANCES
10 July 2021
IGEA Pharma N.V.
IGEA ANNOUNCES ANNUAL GENERAL MEETING RESOLUTIONS
1 July 2021
IGEA Pharma N.V.
IGEA TO LAUNCH THE ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD.
3 June 2021
IGEA Pharma N.V.
IGEA announces changes in its board and other corporate updates